OR WAIT 15 SECS
BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
“We are proud to partner with Health Sciences International and PRL Central Laboratory Services, expanding upon the dozens of CRO partnerships held by BioClinica worldwide,” said Mark Weinstein, CEO of BioClinica, Inc. “Our newest partners demonstrate the quality and continued growth of the BioClinica Certified Partner Program.
Connecticut-based Health Sciences International, Inc. focuses on conducting phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal medicine.
PRL Central Laboratory Services specializes in comprehensive diagnostic testing, focusing on protocol requirements.